- ^ Guérardel, Yann; et al. (2003). "Lipomannan and Lipoarabinomannan from a Clinical Isolate of Mycobacterium kansasii". Journal of Biological Chemistry. 278 (38): 36637–36651. PMID 12829695.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Guérardel, Yann; et al. (2003). "Structural Study of Lipomannan and Lipoarabinomannan fromMycobacterium chelonae". Journal of Biological Chemistry. 277 (34): 30635–30648. PMID 12063260.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Gilleron, Martine; et al. (1997). "Mycobacterium smegmatis Phosphoinositols-Glyceroarabinomannans". PNAS – Microbiology. 271 (1): 117–124. PMID 8995236.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Sibley, LD; et al. (1990). "Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan". Clinical Experimental Immunology. 80 (1): 141–148. PMID 2138940.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Maiti, Debasish; et al. (2001). ". Lipoarabinomannan from Mycobacterium tuberculosis Promotes Macrophage Survival by Phosphorylating Bad through a Phosphatidylinositol 3-Kinase/Akt Pathway". Journal of Biological Chemistry. 276 (1): 329–333. PMID 11020382.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Knutson, Keith; et al. (1998). "Lipoarabinomannan of Mycobacterium tuberculosisPromotes Protein Tyrosine Dephosphorylation and Inhibition of Mitogen-activated Protein Kinase in Human Mononuclear Phagocytes". Journal of Biological Chemistry. 273 (1): 645–652. PMID 9417127.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ {{cite journal |author= Vignal, Cecile, et al. |title= Lipomannans, But Not Lipoarabinomannans, Purified from Mycobacterium chelonae and Mycobacterium kansasii Induce TNF-{alpha} and IL-8 Secretion by a CD14-Toll-Like Receptor 2-Dependent Mechanism |journal= Journal of Immunology |volume=171 |issue=4 |pages=10989-10994|year=2003 |pmid=12902506}}
- ^ Humme, Siblille; et al. (1989). "Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages". Clin Exp Immunol. 76 (2): 240–245. PMID 2503277.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Yu, Weiming; et al. (1998). "Soluble CD141-152 Confers Responsiveness to Both Lipoarabinomannan and Lipopolysaccharide in a Novel HL-60 Cell Bioassay". Journal of Immunology. 161 (8): 4244–4251. PMID 9780199.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Pathak, Sushil Kumar; et al. (2005). "Mycobacterium tuberculosis Lipoarabinomannan-mediated IRAK-M Induction Negatively Regulates Toll-like Receptor-dependent Interleukin-12 p40 Production in Macrophages". Journal of Biological Chemistry. 280 (52): 42794–42800. PMID 16263713.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Chan, J; et al. (1991). "Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect". Infectious Immunology. 59 (5): 1755–1761. PMID 1850379.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Barnes, PF; et al. (1992). "Tumor necrosis factor production in patients with leprosy". Infectious Immunology. 60 (4): 1441–1446. PMID 1548069.
{{cite journal}}: Explicit use of et al. in:|author=(help) - ^ Roach, TI; et al. (1993). "Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha". Journal of Immunology. 150 (5): 1886–1896. PMID 8436823.
{{cite journal}}: Explicit use of et al. in:|author=(help)
Start a discussion with Slnewman1
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. Start a new discussion to connect and collaborate with Slnewman1. What you say here will be public for others to see.
